Advanced in Primitive Neuroectodermal Tumor (PNET)
Advanced in Primitive Neuroectodermal Tumor (PNET)
State University Of Iowa
1221 Pleasant St, Suite 100, 
Des Moines, IA 

Overview

Joshua Lukenbill is an Oncologist and a Hematologist in Des Moines, Iowa. Dr. Lukenbill is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Lung Cancer, Multiple Myeloma, Glioma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Lukenbill is currently accepting new patients.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 120 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Hematology Oncology
Licenses
Internal Medicine in IA
Hospital Affiliations
St Anthony Regional Hospital & Nursing Home
University Of Iowa Hospital & Clinics
Unitypoint Health - Des Moines Iowa Methodist Medi
Humboldt County Memorial Hospital
Mercyone Des Moines Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 17 Less Insurance Carriers -

Locations

STATE UNIVERSITY OF IOWA
1221 Pleasant St, Suite 100, Des Moines, IA 50309

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


117 Clinical Trials

Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Cancer Moonshot Biobank Research Protocol
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Genomically-Guided Treatment Trial in Brain Metastases
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Molecular Analysis for Therapy Choice (MATCH)
Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma
A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC
STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
View 32 Less Clinical Trials
Similar Doctors
Advanced in Primitive Neuroectodermal Tumor (PNET)
Oncology | Hematology
Advanced in Primitive Neuroectodermal Tumor (PNET)
Oncology | Hematology

State University Of Iowa

1221 Pleasant St, Suite 100, 
Des Moines, IA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Steven Heddinger is an Oncologist and a Hematologist in Des Moines, Iowa. Dr. Heddinger is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Paget Disease of the Breast, Pleuropulmonary Blastoma, Lung Cancer, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration. Dr. Heddinger is currently accepting new patients.

Advanced in Primitive Neuroectodermal Tumor (PNET)
Oncology | Hematology
Advanced in Primitive Neuroectodermal Tumor (PNET)
Oncology | Hematology

State University Of Iowa

12495 University Ave, 
Clive, IA 
 (8.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Thomas Buroker is an Oncologist and a Hematologist in Clive, Iowa. Dr. Buroker is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Severe Congenital Neutropenia, Lung Cancer, Pleuropulmonary Blastoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Buroker is currently accepting new patients.

Advanced in Primitive Neuroectodermal Tumor (PNET)
Oncology | Hematology | Hematology Oncology
Advanced in Primitive Neuroectodermal Tumor (PNET)
Oncology | Hematology | Hematology Oncology

State University Of Iowa

1221 Pleasant St, Suite 100, 
Des Moines, IA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Robert Behrens is an Oncologist and a Hematologist in Des Moines, Iowa. Dr. Behrens is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Colorectal Cancer, Lung Cancer, Febrile Neutropenia, Bone Marrow Aspiration, and Colonoscopy. Dr. Behrens is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lukenbill's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 89 Advanced Conditions
    View All 159 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile